Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hattotuwa, K.
Right arrow Articles by Barnes, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hattotuwa, K.
Right arrow Articles by Barnes, N. C.
(Chest. 2002;122:1909-1912.)
© 2002 American College of Chest Physicians

Safety of Bronchoscopy, Biopsy, and BAL in Research Patients With COPD*

Keith Hattotuwa, MD; Elizabeth A. Gamble, MD; Terence O’Shaughnessy, MD; Peter K. Jeffery, PhD and Neil C. Barnes, MD

* From the Department of Respiratory Medicine (Drs. Hattotuwa, Gamble, and Barnes), London Chest Hospital, London; Lung Pathology (Dr. Jeffrey), Department of Gene Therapy, Imperial College School of Medicine, Royal Brompton Hospital, London; and Newham General Hospital (Dr. O’Shaughnessy), London, UK.

Correspondence to: Neil C. Barnes, MD, Department of Respiratory Medicine, London Chest Hospital, Bonner Rd, London, E2 9JX United Kingdom;

Background: Bronchoscopy with biopsy and BAL is being performed increasingly in patients with COPD as a research tool. Previous reports have shown these procedures to be safe in asthmatic patients, but there is little safety data specific to COPD.

Methods: We studied 57 patients with COPD (11 women and 46 men; median FEV1, 1.2 L [range, 0.64 to 2.69 L]; percent predicted FEV1, 44.5% [range, 25 to 74.8%]). Eleven patients had mild disease, 28 patients had moderate disease, and 18 patients had severe disease according to British Thoracic Society classification. Ninety-eight bronchoscopies were performed according to American Thoracic Society guidelines: 68 procedures with endobronchial biopsy and BAL and 30 procedures with biopsy alone. Controlled oxygen was administered via nasal cannula, and pulse oximetry and vital signs were monitored.

Results: Five adverse events occurred. One patient in the moderate-disease group had severe bronchospasm requiring 4 days of inpatient treatment. One patient in the severe-disease group had a pneumothorax requiring 7 days of inpatient treatment. There were three episodes of hemoptysis, two with pleuritic pain (in the BAL group) that settled without intervention. No deaths or prolonged morbidity were observed. We found a 2.0% incidence of adverse events requiring hospital treatment and a 3.1% incidence of minor hemoptysis requiring no intervention.

Conclusions: Bronchoscopy, biopsy, and BAL can be performed safely in patients with COPD, including those with severe disease, provided careful assessment is performed and guidelines are adhered to.

Key Words: adverse effects • BAL • biopsy • bronchoscopy • safety






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Chest Physicians.